Diabetes, Digestive, And Kidney Diseases Extramural Research federal funding in Missouri
Diabetes, Digestive, And Kidney Diseases Extramural Research (CFDA 93.847) shows $529,485,732.30 in USAspending.gov obligations with Missouri as place of performance. Two hundred thirty-seven awards sit behind that total. The join is an NIDDK-related HHS listing crossed with a state location field, not Missouri's entire research or health budget and not a count of patients. The dollars are commitments, not Treasury outlays.
Key figures
- CFDA 93.847 in Missouri shows $529,485,732.30 in USAspending obligations on 237 awards.
- The listing is NIDDK extramural research, not clinical care or Missouri's full health budget.
- Two hundred thirty-seven awards are rows, not a patient or laboratory census.
- The total is commitments, not clinic bills or a disease ranking.
Missouri x 93.847 is a research join, not a patient census
This page pairs CFDA 93.847, DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH, with Missouri place of performance. The listing covers extramural research in diabetes, digestive, and kidney diseases, not clinical care payments and not intramural NIH labs. SpendingVault sums tagged obligations: $529,485,732.30 on 237 awards. The extract does not list investigators, institutions, or disease splits. Treat the pair as a catalog intersection, not a ranking of which state has more diabetes, and not a claim that 237 awards equal 237 laboratories.
Other HHS research listings — other NIH institutes or CDC programs — sit outside $529,485,732.30 unless they also carry 93.847. Mixing those codes would invent a combined biomedical figure the packet never computed. Correlation between this obligation sum and disease prevalence is not causation. Prevalence figures are not in the packet. Place of performance as Missouri locates the tagged awards; it does not deposit $529,485,732.30 in clinic accounts.
237 awards behind $529.5 million
Award count is a row count of assistance awards, including possible competing renewals and supplements. It is not a census of labs, investigators, or patients. Mean obligation is about $2,234,117 if $529,485,732.30 were divided evenly across 237 lines — a mechanical ratio, not a typical grant size, and not a published cost per study. The packet has no diabetes-versus-kidney split inside 93.847.
Two hundred thirty-seven lines are too many to narrate one by one. Sort the Missouri 93.847 overlay by amount to see concentration. This page will not invent institution names. Open Diabetes, Digestive, And Kidney Diseases Extramural Research in Missouri for the stored table. Do not convert 237 into a map of Missouri laboratories. The $529,485,732.30 total remains an obligation rollup on tagged awards.
Research obligations are not clinic bills already paid
Research awards often obligate in budget periods and draw over multiple years. The $529,485,732.30 headline is the obligation sum, not a punch-list of patients treated and not a Treasury outlay total. No fiscal year is attached. An NIDDK funding table dated to a particular year is not automatically this join unless it uses CFDA 93.847, Missouri geography, and the obligation metric.
The listing title is Diabetes, Digestive, And Kidney Diseases Extramural Research. This extract does not split diabetes from digestive or kidney work, and it does not split universities from other performers. Those cuts would require award documentation beyond dollars, 237 awards, CFDA 93.847, and Missouri. This page will not invent a share.
What the Missouri 93.847 table omits
The extract has no investigator list, no disease split, and no patient count. Facts remain $529,485,732.30, 237 awards, CFDA 93.847, and Missouri. This page will not invent a ranking against other states' 93.847 joins. Medical schools and other performers can both sit in the file; the extract does not label them.
Missouri federal spending and Missouri programs place 93.847 among other listings. CFDA 93.847 is the national catalog line. All spending ties indexes other CFDA x state pairs. Mixing those shelves would invent a share of HHS spending the packet never computed. The $529,485,732.30 figure is the tagged pair only.
Where the 93.847 x Missouri overlay lives
Start with Diabetes, Digestive, And Kidney Diseases Extramural Research in Missouri for the 237-award table behind $529,485,732.30. CFDA 93.847 is the nationwide listing. Missouri federal spending and Missouri programs give state context. All spending ties is the shelf for other program-by-state joins on the same obligation metric. Two hundred thirty-seven awards are assistance rows, not a patient census. Investigator names and disease splits are not in this packet.
Readers who need a different program or a different state should leave this URL rather than adding numbers by hand. The $529,485,732.30 figure is the tagged CFDA 93.847 × Missouri pair only. USAspending.gov remains the source; SpendingVault republishes the join. Place of performance is a geography tag on awards, not proof that every dollar stayed inside Missouri after obligation. If a later extract revises the rollup, this page's facts will be stale until the packet is rebuilt. Do not annualize $529,485,732.30 into a per-year run rate: no fiscal year is in the facts.
How to read the Missouri × CFDA 93.847 pair
A ties page exists because two tables meet. One table is the assistance listing (CFDA 93.847). The other is place of performance as Missouri. The headline $529,485,732.30 is the obligation sum on that intersection. It is not a forecast, not a budget request, and not an outlay. It is also not a claim that CFDA 93.847 caused Missouri's economy to grow, or that Missouri caused CFDA 93.847 awards to exist. Correlation between geography and a catalog code is the join — nothing more.
Use the internal links to step off this pair: the statewide spending shelf, the national program listing, the state's other programs, and the ties index. Each of those pages uses the same obligation metric unless a page says otherwise. If you need award-level names, open the overlay or the stored table rather than treating this narrative as a recipient directory. If you need a different metric — outlays, current-year only, or a different geography — that metric is not in this packet.
Questions
- How much NIDDK extramural research is obligated in Missouri?
- USAspending.gov shows $529,485,732.30 in obligations for CFDA 93.847 with Missouri as place of performance, across 237 awards. The sum is a commitment total on assistance awards, not outlays and not Missouri's full research or health budget. Other NIH listings are outside this join unless they also carry 93.847.
- Do 237 awards mean 237 Missouri laboratories?
- No. Award count is a row count of assistance awards and can include renewals and supplements. It is not a lab, investigator, or patient census. The packet does not name institutions. See the Missouri 93.847 overlay for named lines as USAspending stored them.
- Is this Missouri's entire federal biomedical funding?
- No. The join is CFDA 93.847, Diabetes, Digestive, And Kidney Diseases Extramural Research, crossed with Missouri place of performance. Other NIH institutes and clinical-care programs use different listings. Those dollars are not inside $529,485,732.30 unless the award also carries 93.847.
- Is $529 million already spent treating Missouri patients?
- Not on this metric. Obligations are recorded commitments on assistance awards for extramural research. Outlays are payments from the Treasury. The $529,485,732.30 headline is the obligation rollup in SpendingVault's extract. Clinic bills and remaining balances are not published in this packet.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.